These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15597781)

  • 1. [Understanding the pathogenetic mechanisms of SIRS and sepsis and development of innovative therapies of sepsis].
    Aikawa N; Fujishima S
    Nihon Rinsho; 2004 Dec; 62(12):2173-6. PubMed ID: 15597781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues.
    Fry DE
    Am Surg; 2012 Jan; 78(1):1-8. PubMed ID: 22273282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sepsis. I. [Definition of the concept and comments on pathophysiology].
    Makovický P; Mokán M; Vladár L; Vrlík M
    Cas Lek Cesk; 1996 Sep; 135(18):580-3. PubMed ID: 8998797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basic concept and definition of SIRS and sepsis--present consideration and future perspectives].
    Hirasawa H; Oda S; Matsuda K; Watanabe E
    Nihon Rinsho; 2004 Dec; 62(12):2177-83. PubMed ID: 15597782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of severity for systemic inflammatory response syndrome and sepsis].
    Kurihara T; Fujishima S; Aikawa N
    Nihon Rinsho; 2004 Dec; 62(12):2291-5. PubMed ID: 15597798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [SIRS (systemic inflammatory response syndrome): clinical entity, definitions, and the significance].
    Kushimoto S; Yamamoto Y
    Nihon Rinsho; 1999 Jan; 57(1):227-35. PubMed ID: 10036967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The usage of therapeutic drugs and its valuation].
    Endo S; Sato N
    Nihon Rinsho; 2004 Dec; 62(12):2313-6. PubMed ID: 15597802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and splanchnic metabolic response to exogenous human growth hormone.
    Dahn MS; Lange MP
    Surgery; 1998 May; 123(5):528-38. PubMed ID: 9591005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sepsis: infection and systemic inflammatory response].
    Holub M
    Cas Lek Cesk; 2007; 146(2):109-14. PubMed ID: 17373103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inflammation and its regulatory system].
    Abeyama K; Maruyama I
    Nihon Rinsho; 2004 Dec; 62(12):2229-35. PubMed ID: 15597789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune monitoring in SIRS and sepsis based on the PIRO model].
    Meisel C; Höflich C; Volk HD
    Dtsch Med Wochenschr; 2008 Nov; 133(45):2332-6. PubMed ID: 18958829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired regulation of cardiac function in sepsis, SIRS, and MODS.
    Werdan K; Schmidt H; Ebelt H; Zorn-Pauly K; Koidl B; Hoke RS; Heinroth K; Müller-Werdan U
    Can J Physiol Pharmacol; 2009 Apr; 87(4):266-74. PubMed ID: 19370080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A scarlet pimpernel for the resolution of inflammation? The role of supra-therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock.
    Wheatley C
    Med Hypotheses; 2006; 67(1):124-42. PubMed ID: 16545917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mimicry of human sepsis in a rat model--prospects and limitations.
    Stahl O; Löffler B; Haier J; Mardin WA; Mees ST
    J Surg Res; 2013 Jan; 179(1):e167-75. PubMed ID: 22482762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study Group.
    Fein AM; Bernard GR; Criner GJ; Fletcher EC; Good JT; Knaus WA; Levy H; Matuschak GM; Shanies HM; Taylor RW; Rodell TC
    JAMA; 1997 Feb; 277(6):482-7. PubMed ID: 9020273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming of circulatory cells in sepsis and SIRS.
    Cavaillon JM; Adrie C; Fitting C; Adib-Conquy M
    J Endotoxin Res; 2005; 11(5):311-20. PubMed ID: 16263005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
    Castillo L; Carcillo J
    Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample asymmetry analysis of heart rate characteristics with application to neonatal sepsis and systemic inflammatory response syndrome.
    Kovatchev BP; Farhy LS; Cao H; Griffin MP; Lake DE; Moorman JR
    Pediatr Res; 2003 Dec; 54(6):892-8. PubMed ID: 12930915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of eicosanoids from white blood cells in sepsis and SIRS.
    Baenkler M; Leykauf M; John S
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():25-33. PubMed ID: 17244952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune response induced by surgical trauma].
    Hirota M; Ogawa M
    Nihon Geka Gakkai Zasshi; 1996 Sep; 97(9):721-5. PubMed ID: 8940682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.